Artelo Biosciences, Inc. (ARTL) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 10.42M | 695K | 1.83M | 2.23M | 1.38M | 2.56M | 4.99M | 6.17M | 8.19M | 10.98M | 13.43M | 14.6M |
| Cash & Short-Term Investments | 10.27M | 600K | 1.72M | 2.07M | 746K | 2.34M | 4.86M | 5.6M | 7.61M | 10.43M | 12.86M | 13.99M |
| Cash Only | 10.27M | 600K | 1.72M | 2.07M | 746K | 2.34M | 4.36M | 881K | 1.2M | 2.81M | 2.64M | 5.72M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 500K | 4.72M | 6.41M | 7.61M | 10.22M | 8.27M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 148K | 95K | 107K | 167K | 636K | 219K | 129K | 566K | 579K | 554K | 10.79M | 611K |
| Total Non-Current Assets | 2.1M | 2.11M | 2.44M | 2.12M | 2.13M | 2.14M | 2.15M | 2.16M | 2.17M | 2.06M | 2.07M | 2.27M |
| Property, Plant & Equipment | 55K | 64K | 73K | 82K | 91K | 99K | 108K | 116K | 124K | 21K | 29K | 39K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M |
| Long-Term Investments | 0 | 0 | 325K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 0 | 197K |
| Total Assets | 12.52M | 2.8M | 4.27M | 4.36M | 3.52M | 4.7M | 7.14M | 8.33M | 10.35M | 13.04M | 15.5M | 16.88M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 256.13% | -40.38% | -40.2% | -47.67% | -66.05% | -63.98% | -53.96% | -50.67% | -43.97% | -36.14% | -30.85% | -30.85% |
| Total Current Liabilities | 5.83M | 4.04M | 4.86M | 5.71M | 2.8M | 1.77M | 697K | 940K | 721K | 1.29M | 921K | 603K |
| Accounts Payable | 0 | 0 | 3.87M | 4.84M | 2.51M | 1.68M | 627K | 863K | 607K | 1.24M | 840K | 523K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 737K | 664K | 875K | 791K | 0 | 0 | 0 | 0 | 0 | 0 | 32K | 34K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 236K | 0 | 0 | 0 | 0 | 0 | -32K | -523K |
| Other Current Liabilities | 5.09M | 3.38M | 0 | 0 | 0 | -3K | 0 | 0 | 0 | 0 | -791K | 46K |
| Current Ratio | 1.79x | 0.17x | 0.38x | 0.39x | 0.49x | 1.44x | 7.15x | 6.56x | 11.36x | 8.51x | 14.58x | 24.22x |
| Quick Ratio | 1.79x | 0.17x | 0.38x | 0.39x | 0.49x | 1.44x | 7.15x | 6.56x | 11.36x | 8.51x | 14.58x | 24.22x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 18K | 29K | 40K | 51K | 59K | 69K | 78K | 87K | 96K | 0 | 0 | 6K |
| Long-Term Debt | 18K | 29K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6K |
| Capital Lease Obligations | 0 | 0 | 40K | 51K | 59K | 69K | 78K | 87K | 96K | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 5.85M | 4.07M | 4.9M | 5.76M | 2.86M | 1.84M | 775K | 1.03M | 817K | 1.29M | 921K | 609K |
| Total Debt | 755K | 693K | 954K | 878K | 95K | 104K | 112K | 120K | 127K | 23K | 32K | 40K |
| Net Debt | -9.52M | 93K | -766K | -1.19M | -651K | -2.23M | -4.25M | -761K | -1.07M | -2.79M | -2.61M | -5.68M |
| Debt / Equity | 0.11x | - | - | - | 0.15x | 0.04x | 0.02x | 0.02x | 0.01x | 0.00x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -22.85x | -10.05x | -27.11x | -43.74x | - | - | - | - | - | - | - | - |
| Total Equity | 6.67M | -1.27M | -633K | -1.41M | 652K | 2.86M | 6.36M | 7.3M | 9.54M | 11.75M | 14.58M | 16.27M |
| Equity Growth % | 923.31% | -144.52% | -109.95% | -119.26% | -93.16% | -75.69% | -56.37% | -55.13% | -45.93% | -39.43% | -33.44% | -31.76% |
| Book Value per Share | 9.03 | -0.54 | -0.27 | -0.82 | 0.07 | 1.76 | 0.66 | 0.75 | 0.99 | 7.37 | 9.89 | 11.39 |
| Total Shareholders' Equity | 6.67M | -1.27M | -633K | -1.41M | 652K | 2.86M | 6.36M | 7.3M | 9.54M | 11.75M | 14.58M | 16.27M |
| Common Stock | 1K | 2K | 2K | 1K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K |
| Retained Earnings | -65.97M | -63.02M | -58.85M | -55.73M | -52.51M | -50.14M | -46.36M | -45.23M | -42.79M | -40.31M | -37.24M | -34.79M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Accumulated OCI | -246K | -272K | -277K | -295K | -227K | -202K | -218K | -203K | -203K | -203K | -199K | -201K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |